Baudax Bio, Inc. announced that it has entered into a share purchase agreement for the gross proceeds of $50 million on August 23, 2023. The transaction will include participation from new investor, Alumni Capital LP.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.008 USD | +23.08% |
|
+6.67% | -63.64% |
06-17 | First Motion for Exclusivity Period Extension Filed by Baudax Bio, Inc. | CI |
02-22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
1st Jan change | Capi. | |
---|---|---|
-63.64% | 420K | |
+38.36% | 52.73B | |
+38.99% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. announced that it expects to receive $50 million in funding from Alumni Capital LP